The scarcity of ox bile and unprecedented complexity of manufacturing makes the supply of cortisone, so-called "miracle" compound for treatment of rheumatoid arthritis, "a drop in the bucket compared to the demand." A delegate to the semiannual two-day meeting of the Southeastern Society of Hospital Pharmacists, which opened Saturday at the Jung hotel, told of the shortage in an interview. He is James F. Badgett, St. Louis, Mo., a representative of a laboratory which pioneered in development of the compound.
Badgett, who will present a paper Sunday on the history of cortisone, cautioned that though it has been heralded by the press as a "miracle" compound, it is still in the investigative stage. "It must be subjected to more rigid clinical trial and use before statements of its future can be made," he said. PHOTO CAPTION READS: DR. VALLEY, MR. BADGETT, MISS SCHNEIDER Discuss Pharmaceutical Trends
